Tidal Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.99M Buy
26,705
+3,285
+14% +$819K 0.01% 745
2025
Q4
$5.64M Buy
23,420
+5,556
+31% +$1.42M 0.01% 605
2025
Q3
$4.89M Buy
17,864
+4,034
+29% +$1.1M 0.01% 594
2025
Q2
$3.57M Sell
13,830
-94,474
-87% -$22.5M 0.02% 531
2025
Q1
$24.2M Sell
108,304
-2,765
-2% -$645K 0.2% 120
2024
Q4
$25.4M Buy
111,069
+6,131
+6% +$1.48M 0.2% 112
2024
Q3
$25.6M Buy
104,938
+92,422
+738% +$20.7M 0.27% 78
2024
Q2
$2.4M Buy
12,516
+3,562
+40% +$723K 0.03% 483
2024
Q1
$1.77M Buy
8,954
+3,294
+58% +$604K 0.03% 594
2023
Q4
$974K Sell
5,660
-822
-13% -$126K 0.02% 643
2023
Q3
$958K Buy
6,482
+2,644
+69% +$478K 0.03% 558
2023
Q2
$839K Buy
3,838
+220
+6% +$49K 0.02% 596
2023
Q1
$792K Buy
3,618
+228
+7% +$49.5K 0.03% 578
2022
Q4
$706K Buy
3,390
+314
+10% +$69K 0.03% 554
2022
Q3
$671K Buy
3,076
+140
+5% +$31.9K 0.03% 474
2022
Q2
$615K Sell
2,936
-1,152
-28% -$245K 0.02% 528
2022
Q1
$991K Buy
4,088
+458
+13% +$111K 0.03% 425
2021
Q4
$946K Buy
3,630
+475
+15% +$123K 0.03% 424
2021
Q3
$832K Buy
3,155
+556
+21% +$152K 0.03% 381
2021
Q2
$641K Buy
2,599
+692
+36% +$145K 0.03% 381
2021
Q1
$370K Buy
1,907
+616
+48% +$124K 0.02% 368
2020
Q4
$274K Buy
+1,291
New +$257K 0.02% 332

Other funds holding RMD

Tidal Investments's RMD Position: Q1 2026 in Review

Tidal Investments increased its ResMed (RMD) stake by 14% in Q1 2026, buying an estimated $819K and bringing the position to 26,705 shares worth $5.99M. The position accounts for 0.01% of the portfolio, ranked #745.

Tidal Investments first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $25.6M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Tidal Investments held 26,705 shares of ResMed worth $5.99M as of Q1 2026.
  • Tidal Investments bought 3,285 ResMed shares in Q1 2026, an estimated $819K.
  • ResMed made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #745 holding.
  • Tidal Investments first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
  • Tidal Investments's ResMed position peaked at $25.6M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.